Target intelligence / Profile preview

Zinc finger and BTB domain-containing protein 25 (ZBTB25)

Target
ZBTB25
Molecular classification
Transcription factor, Zinc finger protein, POZ and Krüppel (POK) family (BTB/POZ zinc finger protein)
01

Overview

Zinc finger and BTB domain-containing protein 25 (ZBTB25) is a transcriptional repressor belonging to the broad complex, tram track, bric-a-brac/poxvirus and zinc finger (BTB/POZ) family of transcription factors[1]. It contains a DNA-binding zinc finger motif at its C-terminus and a protein-binding BTB/POZ domain at the N-terminus, mediating both protein–DNA and protein–protein interactions[1]. ZBTB25 forms part of corepressor complexes, such as those with histone deacetylase 1 (HDAC1) and Sin3a, to actively repress transcription at specific gene promoters—particularly interleukin-12B (IL-12B)—with important roles in immune regulation during infection (e.g., *Mycobacterium tuberculosis*)[1]. Suppression of ZBTB25 derepresses immune gene expression and induces autophagy, providing a rationale for its pursuit as a host-directed therapy target in tuberculosis[1]. It also interacts with viral polymerase complexes, such as the influenza A viral RNA-dependent RNA polymerase (RdRp), where it enhances viral RNA synthesis and suppresses the host interferon response, making it a potential target for antiviral intervention[2]. Compounds such as disulfiram and specialized zinc-ejectors (e.g., DP) can inactivate ZBTB25 by targeting its zinc finger domain, inhibiting its function and disrupting its roles in infection and viral replication[1][2]. Members of the ZBTB family, including ZBTB25, have broader implications in cancer and immune disease due to their general epigenetic and immune regulatory activities[1].

Other names
C14orf51KUPZNF46Zinc finger protein 46Zinc finger protein KUP
02

Mechanism of action

Zinc finger domain ejection/inhibition (loss of protein function via zinc removal), Inhibition of transcriptional repression, Interference with protein–protein and protein–nucleic acid interactions

03

Biological functions

Transcriptional repressionChromatin remodelingEpigenetic regulationImmune modulationAutophagy regulationViral RNA replication enhancement
04

Disease associations

Infection (notably influenza and tuberculosis)Cancer (indirectly suggested by family function)Other (broad disease relevance via epigenetic and immune regulation)
05

Safety considerations

Potential for broad gene regulation effects due to transcription factor and chromatin remodeling rolespossible off-target immunomodulationautophagy disturbance
06

Interacting drugs

Disulfiram (DSF)

1 more in the full profile.

Beyond the preview

Go deeper on Zinc finger and BTB domain-containing protein 25 (ZBTB25).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger and BTB domain-containing protein 25 (ZBTB25).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call